{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:50:31Z","timestamp":1792155031926,"version":"4.4.0"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2016,9,6]],"date-time":"2016-09-06T00:00:00Z","timestamp":1473120000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["KLI 523-B27"],"award-info":[{"award-number":["KLI 523-B27"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0162460","type":"journal-article","created":{"date-parts":[[2016,9,6]],"date-time":"2016-09-06T13:37:03Z","timestamp":1473169023000},"page":"e0162460","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":234,"title":["Quantitative Susceptibility Mapping in Parkinson's Disease"],"prefix":"10.1371","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7097-9707","authenticated-orcid":true,"given":"Christian","family":"Langkammer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Pirpamer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Seiler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Deistung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinand","family":"Schweser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Franthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Homayoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Katschnig-Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariella","family":"Koegl-Wallner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Pendl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva Maria","family":"Stoegerer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karoline","family":"Wenzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz","family":"Fazekas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Ropele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen Rainer","family":"Reichenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhold","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Schwingenschuh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,9,6]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2011.12.054","article-title":"Iron dysregulation in movement disorders","volume":"46","author":"P Dusek","year":"2012","journal-title":"Neurobiol Dis"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jtemb.2014.05.007","article-title":"The neurotoxicity of iron, copper and manganese in Parkinson\u2019s and Wilson's diseases","volume":"31","author":"P Dusek","year":"2015","journal-title":"J Trace Elem Med Biol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nrn3453","article-title":"Iron metabolism in the CNS: implications for neurodegenerative diseases","volume":"14","author":"T A Rouault","year":"2013","journal-title":"Nat Rev Neurosci. Nature Publishing Group"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/01.rmr.0000245461.90406.ad","article-title":"Role of iron in neurodegenerative disorders","volume":"17","author":"D Berg","year":"2006","journal-title":"Top Magn Reson Imaging"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/j.1471-4159.2010.07132.x","article-title":"The relevance of iron in the pathogenesis of Parkinson\u2019s disease","volume":"118","author":"J Sian-H\u00fclsmann","year":"2011","journal-title":"J Neurochem"},{"key":"ref6","article-title":"International review of neurobiology","author":"P Dusek","year":"2013"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e57904","DOI":"10.1371\/journal.pone.0057904","article-title":"Is R2* a new MRI biomarker for the progression of Parkinson\u2019s disease? A longitudinal follow-up","volume":"8","author":"M Ulla","year":"2013","journal-title":"PLoS One"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1148\/radiol.10100495","article-title":"Quantitative MR imaging of brain iron: a postmortem validation study","volume":"257","author":"C Langkammer","year":"2010","journal-title":"Radiology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/jmri.24768","article-title":"Susceptibility-weighted imaging and quantitative susceptibility mapping in the brain","volume":"42","author":"C Liu","year":"2015","journal-title":"J Magn Reson Imaging"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/j.neuroimage.2012.05.067","article-title":"Quantitative susceptibility mapping for investigating subtle susceptibility variations in the human brain","volume":"62","author":"F Schweser","year":"2012","journal-title":"Neuroimage. Elsevier Inc."},{"key":"ref11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000353756","article-title":"MRI for iron mapping in Alzheimer\u2019s disease","volume":"13","author":"C Langkammer","year":"2014","journal-title":"Neurodegener Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/j.neuroimage.2012.05.049","article-title":"Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study","volume":"62","author":"C Langkammer","year":"2012","journal-title":"Neuroimage"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.neuroimage.2014.11.010","article-title":"Validation of quantitative susceptibility mapping with Perls\u2019 iron staining for subcortical gray matter","volume":"105","author":"H Sun","year":"2015","journal-title":"Neuroimage"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.mri.2015.02.021","article-title":"Quantifying brain iron deposition in patients with Parkinson\u2019s disease using quantitative susceptibility mapping, R2 and R2","volume":"33","author":"JHO Barbosa","year":"2015","journal-title":"Magn Reson Imaging"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.3174\/ajnr.A4260","article-title":"Usefulness of quantitative susceptibility mapping for the diagnosis of Parkinson disease","volume":"36","author":"Y Murakami","year":"2015","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref16","article-title":"Lateral Asymmetry and Spatial Difference of Iron Deposition in the Substantia Nigra of Patients with Parkinson Disease Measured with Quantitative Susceptibility Mapping","author":"M Azuma","year":"2016","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1002\/hbm.22928","article-title":"Region-specific disturbed iron distribution in early idiopathic Parkinson\u2019s disease measured by quantitative susceptibility mapping","volume":"36","author":"N He","year":"2015","journal-title":"Hum Brain Mapp"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1148\/radiol.13121991","article-title":"Improved subthalamic nucleus depiction with quantitative susceptibility mapping","volume":"269","author":"T Liu","year":"2013","journal-title":"Radiology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases","volume":"55","author":"AJ Hughes","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref20","first-page":"189","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"MF Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/S0140-6736(03)13616-1","article-title":"Progression of cerebral white matter lesions: 6-year results of the Austrian Stroke Prevention Study","volume":"361","author":"R Schmidt","year":"2003","journal-title":"Lancet"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/mds.25383","article-title":"How to identify tremor dominant and postural instability\/gait difficulty groups with the movement disorder society unified Parkinson\u2019s disease rating scale: comparison with the unified Parkinson's disease rating scale","volume":"28","author":"GT Stebbins","year":"2013","journal-title":"Mov Disord"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e0125455","DOI":"10.1371\/journal.pone.0125455","article-title":"Neural substrates of motor and non-motor symptoms in Parkinson\u2019s disease: a resting FMRI study","volume":"10","author":"K Yoo","year":"2015","journal-title":"PLoS One"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1002\/mds.23429","article-title":"Systematic review of levodopa dose equivalency reporting in Parkinson\u2019s disease","volume":"25","author":"CL Tomlinson","year":"2010","journal-title":"Mov Disord"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: onset, progression and mortality","volume":"17","author":"MM Hoehn","year":"1967","journal-title":"Neurology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/mds.22340","article-title":"Movement Disorder Society-sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results","volume":"23","author":"CG Goetz","year":"2008","journal-title":"Mov Disord"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.neuroimage.2011.07.019","article-title":"Fast and tissue-optimized mapping of magnetic susceptibility and T2* with multi-echo and multi-shot spirals","volume":"59","author":"B Wu","year":"2012","journal-title":"Neuroimage"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1016\/j.neuroimage.2010.10.070","article-title":"Quantitative imaging of intrinsic magnetic tissue properties using MRI signal phase: an approach to in vivo brain iron metabolism?","volume":"54","author":"F Schweser","year":"2010","journal-title":"Neuroimage. Elsevier B.V."},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.neuroimage.2010.11.088","article-title":"Quantitative susceptibility mapping of human brain reflects spatial variation in tissue composition","volume":"55","author":"W Li","year":"2011","journal-title":"Neuroimage. Elsevier Inc."},{"key":"ref30","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.neuroimage.2010.01.101","article-title":"Improved tractography alignment using combined volumetric and surface registration","volume":"51","author":"L Z\u00f6llei","year":"2010","journal-title":"Neuroimage"},{"key":"ref31","first-page":"208","article-title":"Advances in functional and structural MR image analysis and implementation as FSL","volume":"23","author":"S Smith","year":"2004","journal-title":"Neuroimage. ACADEMIC PRESS INC ELSEVIER SCIENCE"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1471-4159.1958.tb12607.x","article-title":"The effect of age on the non-haemin iron in the human brain","volume":"3","author":"B Hallgren","year":"1958","journal-title":"J Neurochem"},{"key":"ref33","article-title":"Quantitative susceptibility mapping of the midbrain in Parkinson\u2019s disease","author":"G Du","year":"2015","journal-title":"Mov Disord"},{"key":"ref34","article-title":"Regionally progressive accumulation of iron in Parkinson\u2019s disease as measured by quantitative susceptibility mapping","author":"X Guan","year":"2016","journal-title":"NMR Biomed"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e0145493","DOI":"10.1371\/journal.pone.0145493","article-title":"Potential of Diffusion Tensor Imaging and Relaxometry for the Detection of Specific Pathological Alterations in Parkinson\u2019s Disease (PD)","volume":"10","author":"R Esterhammer","year":"2015","journal-title":"PLoS One"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1148\/radiol.12120707","article-title":"Quantitative susceptibility mapping in multiple sclerosis","volume":"267","author":"C Langkammer","year":"2013","journal-title":"Radiology"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/jmri.24644","article-title":"Increase in the iron content of the substantia nigra and red nucleus in multiple sclerosis and clinically isolated syndrome: a 7 Tesla MRI study","volume":"41","author":"AI Blazejewska","year":"2015","journal-title":"J Magn Reson Imaging"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.neuroimage.2012.09.055","article-title":"Toward in vivo histology: a comparison of quantitative susceptibility mapping (QSM) with magnitude-, phase-, and R2*-imaging at ultra-high magnetic field strength","volume":"65","author":"A Deistung","year":"2013","journal-title":"Neuroimage. Elsevier Inc."},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/mds.26199","article-title":"Selective dysfunction of basal ganglia subterritories: From movement to behavioral disorders","volume":"30","author":"L Tremblay","year":"2015","journal-title":"Mov Disord"},{"issue":"Suppl 3","key":"ref40","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/S1353-8020(09)70770-9","article-title":"Non-motor extranigral signs and symptoms in Parkinson\u2019s disease","volume":"15","author":"EC Wolters","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1001\/jamaneurol.2014.391","article-title":"Measuring disease progression in early Parkinson disease: the National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experience","volume":"71","author":"SA Parashos","year":"2014","journal-title":"JAMA Neurol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/mds.22335","article-title":"UPDRS activity of daily living score as a marker of Parkinson\u2019s disease progression","volume":"24","author":"MB Harrison","year":"2009","journal-title":"Mov Disord"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/jmri.22752","article-title":"High resolution magnetic susceptibility mapping of the substantia nigra in Parkinson\u2019s disease","volume":"35","author":"AK Lotfipour","year":"2012","journal-title":"J Magn Reson Imaging"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1002\/hbm.21404","article-title":"Direct visualization of the subthalamic nucleus and its iron distribution using high-resolution susceptibility mapping","volume":"33","author":"A Sch\u00e4fer","year":"2012","journal-title":"Hum Brain Mapp"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/mrm.24629","article-title":"On the role of neuronal magnetic susceptibility and structure symmetry on gradient echo MR signal formation","volume":"71","author":"AL Sukstanskii","year":"2014","journal-title":"Magn Reson Med"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1089\/ars.2013.5593","article-title":"Targeting chelatable iron as a therapeutic modality in Parkinson\u2019s disease","volume":"21","author":"D Devos","year":"2014","journal-title":"Antioxid Redox Signal"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12883-015-0331-3","article-title":"Ceruloplasmin activity and iron chelation treatment of patients with Parkinson\u2019s disease","volume":"15","author":"G Grolez","year":"2015","journal-title":"BMC Neurol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0162460","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T02:59:00Z","timestamp":1568343540000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0162460"}},"subtitle":[],"editor":[{"given":"Jan","family":"Kassubek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,9,6]]},"references-count":47,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2016,9,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0162460","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,6]]}}}